Several trends shaping the future of biopharma will have a direct impact on workforce development. First, a 2018 report from BioPlan Associates estimates there are well over 10,000 therapeutics in R&D, both drugs (chemical substance pharmaceuticals) and biopharmaceuticals (biotechnology-derived pharmaceuticals), with nearly 40,000 ongoing (or recently reported) clinical trials. Advances in cell and gene therapies are predicted to disrupt the biomanufacturing industry, requiring new techniques and technologies to be established. The need for process development expertise increases and biopharma companies are finding it difficult to fill these positions.
March 18, 2019
Biomanufacturing: The Cost of Unskilled Workers
Strategies your company should consider for recruiting, training and retaining staff